Raymond Debbane's most recent trade in Lexicon Pharmaceuticals Inc was a trade of 103,806 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,806 | 103,806 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 89,312 | 89,312 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 36,810 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 36,810 | 1,385,689 (1%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 44,906 | 44,906 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 36,810 | 36,810 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2024 | 8,032 | 1,348,879 (1%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2024 | 8,032 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2023 | 9,302 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2023 | 9,302 | 340,847 (0%) | 0% | 0 | Common Stock | |
| WW International Inc | Raymond Debbane | Former Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 835 | 134,387 (0%) | 0% | 0 | Common Stock | |
| WW International Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 2,053 | 133,552 (0%) | 0% | 0 | Common Stock | |
| WW International Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 5,067 | 131,499 (0%) | 0% | 0 | Common Stock | |
| WW International Inc | Raymond Debbane | Director | Purchase of securities on an exchange or from another person at price $ 4.27 per share. | 10 Nov 2022 | 75,000 | 126,432 (0%) | 0% | 4.3 | 320,055 | Common Stock |
| WW International Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 4,595 | 51,432 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 01 Aug 2022 | 982,600 | 5,303,814 (4%) | 0% | 2.5 | 2,456,500 | Common Stock |
| WW International Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jul 2022 | 2,745 | 46,837 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2022 | 14,402 | 14,402 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2022 | 9,302 | 9,302 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2022 | 4,024 | 331,545 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2022 | 4,024 | 0 | - | - | Restricted Stock Units | |
| WW International Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 1,797 | 44,092 (0%) | 0% | 0 | Common Stock | |
| WW International Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 15.90 per share. | 03 Jan 2022 | 1,179 | 42,295 (0%) | 0% | 15.9 | 18,746 | Common Stock |
| WW International Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 18.78 per share. | 04 Oct 2021 | 998 | 41,116 (0%) | 0% | 18.8 | 18,742 | Common Stock |
| WW International Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 35.84 per share. | 05 Jul 2021 | 523 | 40,118 (0%) | 0% | 35.8 | 18,744 | Common Stock |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 6,475 | 6,475 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 4,024 | 4,024 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2021 | 10,638 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Raymond Debbane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2021 | 10,638 | 327,521 (0%) | 0% | 0 | Common Stock | |
| WW International Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 30.77 per share. | 05 Apr 2021 | 609 | 39,595 (0%) | 0% | 30.8 | 18,739 | Common Stock |
| WW International Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 724 | 38,986 (0%) | 0% | 0 | Common Stock | |
| WW International Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2020 | 996 | 38,262 (0%) | 0% | 0 | Common Stock |